Amlopine

Quick links to important sections

Amlopine

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlopine

What is Amlopine?

Amlopine is a systemic, synthetic medication that contains the single active ingredient, Amlodipine (INN, often as Amlodipine besylate). The drug is classified as a Calcium Channel Blocker (CCB) belonging to the Dihydropyridine group, a distinction within pharmaceutical classifications. This agent is strictly available as a Prescription-Only Medicine for use in monotherapy.

Property Description
Active ingredient Amlodipine (typically as besylate salt)
Form Oral tablet, Oral solution, Oral suspension
Pharmacological class Calcium Channel Blocker (CCB)
General purpose Antihypertensive and Antianginal agent
Origin Synthetic, Small molecule

General Therapeutic Purpose and Mechanism

The general purpose of Amlopine is to act as both an Antihypertensive (blood pressure lowering) and an Antianginal (chest discomfort relieving) agent. The drug functions by promoting the relaxation and widening of the peripheral arteries, a process known as vasodilation, which lessens the resistance against which the heart must pump. Amlodipine is characterized as an effective agent within its class for the management of high blood pressure. This action of widening blood vessels makes it easier for the heart to circulate blood.


Available Pharmaceutical Forms

Amlopine is a long-acting agent manufactured for Oral administration in several Pharmaceutical Preparations. While the most common form is the Oral Tablet, it is also supplied as an Oral Solution and an Oral Suspension. The availability of these distinct forms ensures that the medication can be administered to varied patient populations, including children aged six years and older or adults who have difficulty swallowing.

Regulatory References

  1. NIH Amlodipine Study

What side effects are possible with Amlopine?

Possible Side Effects and Safety Information

The official safety documentation for Amlopine outlines possible adverse reactions categorized by how frequently they were observed in clinical studies and post-marketing reports.

Frequency-Classified Adverse Reactions

Adverse reactions are classified according to the following observed frequencies:

Classification Examples of Reactions
Common (1 in 100 to less than 1 in 10) Edema (swelling), headache, fatigue, somnolence, dizziness, abdominal pain, nausea, flushing, palpitation.
Uncommon (1 in 1,000 to less than 1 in 100) Insomnia, mood changes, tremor, vomiting, dyspepsia, dry mouth, rash, muscle cramps, joint pain, impotence, weight changes.
Very Rare (less than 1 in 10,000) Myocardial infarction, arrhythmia, vasculitis, allergic reactions (e.g., angioedema), pancreatitis, hepatitis, jaundice, severe skin reactions (e.g., Stevens-Johnson syndrome).

Serious Safety Considerations and Restrictions

Serious Adverse Reactions documented in regulatory sources include cardiac events such as myocardial infarction and arrhythmias, as well as blood disorders (leukopenia) and severe skin reactions (toxic epidermal necrolysis, erythema multiforme).

Safety Restrictions (Contraindications): Amlopine is contraindicated in specific high-risk situations, including known hypersensitivity to the drug or its class, severe hypotension, cardiogenic shock, and obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).

Population-Specific Caution: Patients with impaired liver function require particular caution due to the drug's prolonged presence in their system, necessitating a lower starting dose. Official warnings note that an increase in the frequency or severity of angina or an acute myocardial infarction may occur upon starting or increasing the dose, especially in patients with severe obstructive coronary artery disease.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Amlopine (Amlodipine) is officially documented to result primarily from the exaggeration of its known effects, leading to severe cardiovascular manifestations. The chief clinical signs are excessive peripheral vasodilatation and marked and prolonged systemic hypotension, which are documented in official prescribing information as potentially escalating to shock with a fatal outcome. Other manifestations documented include reflex tachycardia, dizziness, fainting, and neurological changes such as confusion or seizure. A severe, but potentially delayed, complication reported in regulatory documents is non-cardiogenic pulmonary oedema.

Because no specific antidote is known for Amlodipine, the official regulatory guidance mandates a management strategy of strictly symptomatic and supportive treatment, including active cardiovascular support and fluid administration. Due to the drug’s long elimination half-life, extended clinical monitoring is required to observe for the persistence or recurrence of effects.

Immediate medical attention must be sought for any suspected overdose. Emergency services must be contacted immediately if a person exhibits severe symptoms such as collapse, trouble breathing, or seizure. The Poison Control Helpline is also cited in official guidance for specific overdose management protocols.

Therapeutic Uses of Amlopine

What Amlopine Treats: Main Uses and Benefits

Amlopine is a medication applied across domains where additional symptomatic support is needed for conditions presenting with systemic or localized discomfort in the cardiovascular system.

Amlopine is relevant for easing symptoms associated with conditions such as hypertension (high blood pressure) and coronary artery disease (CAD). Specifically, it is commonly used to help with symptoms related to both chronic stable angina and vasospastic (Prinzmetal’s or variant) angina.

In clinical scenarios where symptoms become more noticeable, Amlopine provides support that helps ease the overall symptom burden. For those with hypertension, it contributes to easing the overall symptom load. For patients with CAD, it is applied in scenarios marked by temporary physiological imbalance.

“This medication is considered relevant for easing symptom clusters that may become intense or disruptive during acute episodes.”

The use of Amlopine is intended to help improve day-to-day comfort during symptomatic periods and may assist with managing symptoms that interfere with daily comfort.

Quick Fact: Support for Chest Discomfort
Amlopine supports patients during episodes of heightened discomfort, such as symptoms related to cardiovascular or irritative states.

Eligibility and Restrictions for Use

Amlopine (Amlodipine) eligibility is strictly defined by regulatory authorities based on patient population and pre-existing medical status. Use is established for adults with hypertension or coronary artery disease. Pediatric use is restricted to children aged 6 to 17 years for the treatment of hypertension only; use is not established for children younger than six.

Contraindicated Populations

Official labeling defines several absolute contraindications, meaning Amlopine must not be used in patients with a known sensitivity to amlodipine or other dihydropyridine derivatives. It is also prohibited for patients experiencing severe hypotension, a state of shock, obstruction of the left ventricular outflow tract (e.g., severe aortic stenosis), or haemodynamically unstable heart failure following a heart attack.


Restrictions and Special Considerations

Use requires special caution in elderly patients and those with hepatic impairment, often necessitating a lower starting dose due to altered drug clearance. For pregnancy, safety has not been established; use is generally restricted to situations where the benefit clearly justifies the risk. Amlodipine is excreted in human milk, leading regulators to recommend the discontinuation of nursing.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Amlopine (Amlodipine) based on government regulatory information.


Pharmacokinetic and Pharmacodynamic Interactions

Amlopine's interaction profile is largely governed by its clearance through the CYP3A4 enzyme system. Co-administration with strong or moderate CYP3A4 inhibitors (e.g., Itraconazole, Clarithromycin) is documented to cause a pharmacokinetic interaction that increases Amlopine's systemic exposure. Conversely, CYP3A4 inducers (e.g., Rifampicin) may lead to reduced Amlopine exposure.

Pharmacodynamic interactions occur when Amlopine is combined with other antihypertensive agents, resulting in an additive blood pressure lowering effect.

Interaction-Related Restrictions

Amlopine can increase the systemic exposure of other medicines, which is classified as a pharmacokinetic interaction. A specific restriction is required when co-administered with the cholesterol-lowering medication Simvastatin; the daily dose of Simvastatin must be officially limited to 20 mg. Amlopine may also increase the exposure of the immunosuppressants Cyclosporine and Tacrolimus.


Population and Other Contexts

No mandatory timing separation is required for Amlopine dosing. The elimination process of Amlopine is impaired in patients with hepatic dysfunction, leading to increased systemic exposure. Official documents state no clinically significant interaction is expected with grapefruit or antacids.

Mechanism of Action

How Amlopine Works — Mechanism of Action

Amlodipine acts as a selective inhibitor of L-type voltage-dependent calcium channels (CaV1.x) found predominantly on the membrane of vascular smooth muscle cells (VSMCs).

By binding to these channels, the drug blocks the influx of extracellular calcium ions (Ca^2+) into the cytoplasm. This inhibition interrupts the complex molecular cascade inside VSMCs, preventing the Ca^2+-dependent phosphorylation steps required for the formation of actin-myosin cross-bridges. The resulting lack of contractile activity leads to the relaxation and dilation of peripheral arteries.

This widespread arterial vasodilation decreases the total peripheral vascular resistance (afterload), which is the resistance the heart must overcome to eject blood. This physiological change reduces total peripheral resistance, which results in a decrease in systemic arterial pressure.

Dosage and Administration Information

How to use Amlopine: Administration Guidelines

Amlopine (Amlodipine) is a prescription-only medication administered orally, following dosing and adjustment schedules established in standard prescribing information. Its usage is standardized as a once-daily regimen for long-term therapeutic protocols, independent of meal timing.


Dosing and Administration

Category Instruction
Route of Administration Oral administration only.
Standard Adult Dose Initial dose: 5 mg once daily. Maximum dose: 10 mg once daily.
Timing May be taken with or without food. Recommended to take at the same time each day.
Titration Interval Dose adjustments should generally proceed over 7 to 14 days

Population-Specific Use

Standard pharmacological guidelines provide specific initial dose guidelines for certain patient groups:

  • Older Adults and Hepatic Impairment: A lower initial dose of 2.5 mg once daily may be appropriate for small, fragile, or elderly patients, and those with hepatic insufficiency.
  • Pediatric Patients (Ages 6–17): The effective dose range for children in this age group is 2.5 mg to 5 mg once daily. Doses exceeding 5 mg daily have not been studied in this population.
  • Renal Impairment: No initial dose adjustment is required, as the change in drug concentration does not correlate with the degree of renal impairment.

Missed Dose Instructions

If a dose is missed, the standard protocol is to take it as soon as it is remembered. However, if it has been more than 12 hours since the scheduled time, the missed dose should be skipped, and the patient should resume the next dose at the regular time. Never take two doses simultaneously.

Recent Clinical Evidence

Research evidence / Overview of studies for Amlopine

The research evidence for Amlopine (Amlodipine) is primarily drawn from clinical research conducted to evaluate its application in two major areas: high blood pressure and issues related to coronary artery disease. This overview describes the types of studies that have been conducted and the general patterns observed, but it is not intended to offer clinical advice.


Evidence for use in High Blood Pressure (Hypertension)

Research for Amlopine in the context of high blood pressure has been conducted using well-structured clinical trials. This includes numerous Randomized Controlled Trials (RCTs), comparing the agent to placebo or other antihypertensive drugs. Additionally, extensive meta-analyses have pooled data from these trials, allowing researchers to explore long-term patterns across large numbers of participants.

These studies examined the change in blood pressure (BP), measuring both the maximum pressure (systolic) and minimum pressure (diastolic). Studies also explored whether Amlopine use was associated with patterns in the frequency of major long-term cardiovascular events, such as stroke and myocardial infarction (heart attack). Research has explored patterns related to blood pressure levels and cardiovascular event frequency when comparisons were made to control groups.

Evidence for use in Coronary Artery Disease and Angina

Research has also explored Amlopine in studies involving temporary or heightened discomfort in the cardiovascular system, such as angina and documented coronary artery disease (CAD). Studies have included placebo-controlled trials designed to monitor how symptoms evolved in the observed populations with chronic stable angina and vasospastic angina.

Researchers examined patient-reported outcomes, focusing on changes measured during the study period, such as the self-recorded frequency of angina attacks. Long-term studies monitored the frequency of clinical events, including hospitalization for angina and the need for revascularization procedures. Studies reported how symptoms evolved, describing patterns related to symptom occurrence in the observed populations.

Evidence Gaps and Areas of Uncertainty

Research provides context but not individual predictions, and findings highlight what is known and what is still uncertain. Data for certain groups remain insufficient for long-term prognosis, particularly for the use of Amlopine in patients with severe chronic heart failure. While patterns related to symptom changes was observed in some studies for angina, comparative evidence regarding long-term prognostic patterns is lacking across all specific subgroups. The results apply only to the populations studied and reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Amlodipine (StatPearls/NCBI Bookshelf) - General Therapeutic Review
  2. Effect of amlodipine on the progression of coronary disease and clinical events: prospective randomized evaluation of the vascular effects of nifedipine trial (PREVENT)

Frequently Asked Questions (FAQ)

Common questions about Amlopine (FAQ)


Q: Is Amlopine the same thing as a beta-blocker?

A: Amlopine is officially classified as a dihydropyridine calcium channel blocker (CCB).

This means the medication works by targeting calcium channels in blood vessel walls to widen them, which is a different mechanism than a beta-blocker.


Q: How quickly can I expect Amlopine to start working for high blood pressure?

A: Official product information indicates that the drug’s effects are gradual, with plasma concentrations peaking between 6 and 12 hours after a single dose. The initial antihypertensive effects typically develop over 4 to 8 hours.

The drug is intended for a once-daily, long-term therapeutic regimen.


Q: Are there any foods or drinks I should avoid while taking Amlopine?

A: Regulatory documents note that Amlopine may be taken with or without food.

Furthermore, official sources indicate that no clinically significant interaction is expected with common items like grapefruit or antacids.


Q: Does Amlopine affect kidney function or laboratory tests?

A: Regulatory prescribing information notes that no initial dose adjustment is required for patients with renal (kidney) impairment.

Official documents do not generally list specific effects on routine laboratory tests.


Q: Is Amlopine linked to weight gain or changes in appetite?

A: 'Weight changes' are documented as an uncommon adverse reaction associated with Amlopine use.

This change may be related to fluid retention or edema (swelling), which is a commonly described side effect of this medication class.


Q: Does Amlopine make people dizzy when they stand up?

A: Dizziness is a commonly documented side effect of Amlopine. However, because the drug acts gradually, regulatory information suggests that acute hypotension—a sudden drop in blood pressure when changing posture—is unlikely.


Q: How should Amlopine be stored, and does it expire?

A: Official guidelines specify that Amlopine should be stored at controlled room temperature (e.g., 20 C to 25 C), protected from light and moisture, and kept in its original container.

Like all pharmaceutical products, it has a defined expiration date or shelf life, and expired medicine should be properly disposed of.


Q: Can taking Amlopine at night or in the morning make a difference?

A: Official administration instructions recommend taking Amlopine once daily at approximately the same time each day to maintain consistent drug levels.

The specific time chosen is typically for convenience, provided the dose is taken consistently each day.


Q: Does Amlopine cause low blood pressure (hypotension)?

A: As an antihypertensive agent, Amlopine works to lower blood pressure, which means that low blood pressure (hypotension) is a potential risk.

Severe hypotension is listed in regulatory documents as a condition where Amlopine should not be used (contraindication).


Q: Does Amlopine have a generic version available?

A: Yes, Amlopine is the brand name for the active ingredient, Amlodipine.

Amlodipine is widely available in generic form, according to regulatory nomenclature and product availability status.


Q: Can Amlopine be taken with an upset stomach?

A: Amlopine may be taken with or without food, based on official prescribing instructions.

Taking the medication alongside food may help to mitigate any mild gastrointestinal side effects, such as nausea or stomach discomfort, that are sometimes documented.


Q: Is Amlopine a 'water pill' or diuretic?

A: No, Amlopine is classified as a Calcium Channel Blocker.

Its function is to promote the dilation (widening) of arteries, and it does not work by increasing urine output like a diuretic (or 'water pill') does.


Q: Does Amlopine interact with common pain relievers like Ibuprofen?

A: Regulatory sources indicate that Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), which include medications like ibuprofen, may reduce the blood pressure lowering effects of Amlopine.


Q: If I already have a slow heart rate, can I still use Amlopine?

A: Amlopine is a calcium channel blocker and is not documented to cause clinically significant changes in the heart's rate or rhythm.

Its mechanism primarily affects blood vessels, not the heart's electrical conduction system.


Q: Can Amlopine be split in half if the tablet is scored?

A: Official regulatory guidance permits the splitting of tablets only if the product is explicitly scored for that purpose by the manufacturer.

If a tablet is unscored, splitting is not recommended as it may lead to inconsistent dosing of the active ingredient.


Q: What happens if I stop taking Amlopine suddenly?

A: Regulatory information warns that sudden discontinuation of the drug, particularly for patients with documented severe coronary artery disease, may be associated with an increase in the frequency or severity of angina (chest pain).


Q: What should I do if my blood pressure remains high while taking Amlopine?

A: Amlopine is a gradual-acting medication that requires time to reach its full therapeutic effect.

Regulatory guidance indicates that changes in dosage should generally occur over a period of 7 to 14 days to fully assess the effect.


Q: Is Amlopine a blood thinner?

A: No, Amlopine is classified as a Calcium Channel Blocker.

Its primary action is promoting the widening of blood vessels, and it does not affect blood clotting or blood thickness like a blood thinner (anticoagulant or antiplatelet agent) does.


Q: How do doctors monitor the effectiveness of Amlopine?

A: The effectiveness of Amlopine is assessed in clinical trials by monitoring the reduction achieved in systolic and diastolic blood pressure readings over time.


Q: If I feel better, can I assume Amlopine is working?

A: Amlopine works to lower blood pressure, which is often a condition without subjective symptoms.

Official regulatory efficacy is therefore measured by objective blood pressure readings and not by how a patient feels.


Q: What is the risk of overdose with Amlopine?

A: Official product information describes that an overdose can cause excessive widening of blood vessels.

This may result in marked and possibly prolonged systemic hypotension (very low blood pressure) and a state of shock.


Q: Does Amlopine interact with alcohol?

A: Regulatory information suggests that co-administration with alcohol may lead to additive effects in lowering blood pressure.

This combination may increase the risk of symptoms like dizziness and fainting.


Q: Can Amlopine affect the eyes or vision?

A: Official regulatory documents list visual disturbances as an uncommon adverse reaction experienced during clinical trials.


Q: Does Amlopine work better for certain types of high blood pressure?

A: Clinical data suggests that the magnitude of blood pressure reduction is often correlated with the initial severity of the pretreatment blood pressure elevation.

How should Amlopine be stored and disposed of?

How to Store and Dispose of Amlopine (Amlodipine)

Official regulatory guidelines strictly define how Amlopine must be stored to maintain its quality and how unused medicine must be discarded to protect the environment.

Storage Requirement Official Condition
Temperature Store at 20 C to 25 C (Controlled Room Temperature).
Protection Keep in the original container and protect from light and moisture.
Child Safety Must be kept out of the sight and reach of children.
Liquid Form Stability Oral suspension must be used within 60 days after first opening the bottle and must not be frozen.

Disposal Rules

Expired or unused Amlopine must not be disposed of via household waste or by flushing down the wastewater system. All discarded medicine must be managed according to local requirements for proper pharmaceutical waste collection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlopine found in:

A-Z Index: